摘要：
Objective To review the development of patient-reported outcome measurement (PROM) for patients with psoriasis in China, and to analyze the main results and methodology. Methods The systematic review method of COSMIN (consensus-based standards for the selection of health measurement instruments) was adopted, and the domestic and foreign databases were searched to find the patient-reported outcome scales based on Chinese psoriasis patients. Then, the included studies were evaluated by using COSMIN risk of bias checklist. Results and Conclusion A total of 3 studies were included, involving 3 scales. We found that the quality evaluation of the development process of the 3 scales was not high, and there were large methodological loopholes in the whole cycle of scale development and verification. The included studies have many problems such as low extrapolation, poor quality, and lack of validation, which can provide more insights for the quality control requirements of the whole cycle of scale development in the future.
Li Kexin, Zhang Fang, Huang Zhe.
A Systematic Review of Patient-Reported Outcome Measurement for Psoriasis in Chinese Population
[J]. 亚洲社会药学, 2023, 18(3): 261-280.
Li Kexin, Zhang Fang, Huang Zhe.
A Systematic Review of Patient-Reported Outcome Measurement for Psoriasis in Chinese Population
[J]. Asian Journal of Social Pharmacy, 2023, 18(3): 261-280.
